US20060015089A1 - Catheter and method of fluid removal from a body cavity - Google Patents
Catheter and method of fluid removal from a body cavity Download PDFInfo
- Publication number
- US20060015089A1 US20060015089A1 US11/230,048 US23004805A US2006015089A1 US 20060015089 A1 US20060015089 A1 US 20060015089A1 US 23004805 A US23004805 A US 23004805A US 2006015089 A1 US2006015089 A1 US 2006015089A1
- Authority
- US
- United States
- Prior art keywords
- catheter
- catheter body
- port
- shape
- plural holes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M27/00—Drainage appliance for wounds or the like, i.e. wound drains, implanted drains
Definitions
- the present invention relates to devices that permit repeated access to the peritoneal or thoracic cavities. More particularly, the invention relates to a peritoneal and thoracic cavity port catheter.
- Certain medical conditions are treated by infusing a body cavity with a fluid medical preparation through a catheter with one or more infusion holes at a distal end thereof and with an access port or other such device at a proximal end thereof.
- a catheter comprising a catheter body having a wall defining a lumen therein and having plural holes defined through the wall in a pattern which prevents loculation, migration and blockage of a fluid flow through the lumen, the catheter body having a tissue-puncture resistant shape; and a port having a reservoir capable of multiple needle accesses.
- FIG. 1 is a top view of a catheter and port embodying aspects of the invention
- FIG. 2 is a cross sectional detail view of the catheter of FIG. 1 , taken along line 1 - 1 ;
- FIG. 3 is a perspective view of the catheter of FIG. 1 ;
- FIG. 8 is an end view of the catheter of FIG. 7 ;
- FIG. 9 is a top view of the catheter of FIGS. 7-8 , extended by a pusher rod shown in phantom;
- FIG. 10 shows a cross section of a patient's peritoneal cavity, into whose wall another configuration of port and catheter has been implanted;
- FIG. 11 is a side view of the distal end of the catheter body of FIG. 10 ;
- FIG. 12 is an end view of the catheter body of FIG. 10 ;
- FIG. 14 is a cross-sectional side view of a removable core access needle used in various embodiments.
- FIG. 15 is a side view of a catheterless plug
- FIGS. 16, 17 and 18 are side, top and front views, respectively, of an alternate port design
- FIG. 19 is a side view of a combined catheter shape
- FIGS. 20 and 21 are end and side views, respectively, of an alternate combined catheter shape.
- FIGS. 22 and 23 are side and top views, respectively, of a port design having a right-angle outlet.
- a method and apparatus for removal of fluids from a patient's body, for example draining fluids from a body cavity between multiple drug infusion operations (e.g., during the entire duration of treatment).
- Embodiments of aspects of the invention may include a catheter or a catheterless plug having a catheter body and an access port, and a method of extracting fluid from a body cavity.
- the catheterless plug has a body resembling a catheter body, but which can comprise a fully integrated unit. References below to the catheter body apply to the body of the catheterless plug, as well, except where differences are explicitly mentioned.
- the catheter body should preferably have a shape that is unlikely to undesirably puncture or injure tissue or organs encountered in or about the body cavity to be drained.
- the shape of the catheter body, together with the placement of one or more fluid extraction holes in a wall of the catheter body should preferably be such as to avoid the formation of pockets (referred to by those skilled in this art as loculation) and/or to avoid creating a fluid flow that would cause migration of the catheter body, or of tissue or debris, that could block the extraction holes.
- the extraction holes can be positioned in a protected region of the catheter body, as described below.
- the catheter port should preferably be implantable subcutaneously, and/or capable of sufficient extraction needle passages to complete a course of treatment without replacement.
- a catheter 10 including a catheter body 100 ( FIGS. 1-3 ) having a lumen ( FIG. 2, 200 ) that may be closed off at the distal end 101 , i.e., having no end hole.
- This embodiment includes plural holes 102 covering a combined surface area suitable for withdrawing fluid, substantially without clogging.
- an end hole can be provided at the distal end 101 of catheter body 100 , together with one or more other holes 102 , provided neither a hole 102 nor the optional end hole contributes such a surface area, and consequently large fluid flow, as to induce loculation or migration of the catheter body 100 .
- the catheter body 100 of this embodiment is quite long.
- One danger inherent in implanting a catheter 10 in many body cavities is the risk of perforating or puncturing an organ, membrane, or other tissue unintentionally.
- the risk is especially large when a long catheter body 100 is implanted into a closed cavity such as the peritoneal cavity, with the expectation that the catheter will bunch up like spaghetti.
- the catheter body 100 is a self-coiling type to facilitate insertion of such a relatively long catheter into the body. This may be achieved by means known to the skilled practitioner such as molding the catheter body 100 in a desired coil configuration, molding the catheter body 100 on a coiled strength member such as a wire, etc.
- the coil may be flat, a straight-sided helix, a conical helix, etc.
- FIGS. 1-3 employs a flat coil pigtail configuration, although other coil configurations, as well as configurations that avoid perforation or puncture using other shapes, as explained below, are possible.
- the holes 102 should be positioned to avoid contact with adjacent tissues or occluding masses.
- the holes 102 of this embodiment are positioned on the inner curve 107 of the coil so as to avoid contact between the holes 102 and adjacent tissues.
- the outer curve 108 and the sides 109 can be devoid of holes.
- the holes 102 are in a protected region of the catheter body.
- inner curve refers to that part of the surface of a coil-shaped catheter body 100 facing a central axis of the coil of the catheter body 100 .
- outer curve is that part of the surface of the coil-shaped catheter body 100 facing away from a central axis of the coil of the catheter body 100 .
- sides are surfaces of the coil-shaped catheter body 100 adjacent to both the inner curve 107 and outer curve 108 and joining them.
- an alternate embodiment of a catheter 500 has a catheter body 501 with a shape such as a simple helix or corkscrew, that avoids punctures. Holes 102 are disposed on the inner curve 502 of the catheter body 501 to avoid contact between the holes 102 and adjacent tissues. Again, the holes 102 are located in a protected region of the catheter body.
- This catheter 500 and the catheter 10 of FIGS. 1-3 can optionally include an end hole (not shown) at the distal end 503 provided the area of the end hole is properly balanced against the areas of the holes 102 .
- catheter body 600 has a T-bar shape.
- the terminuses 601 may be closed or may optionally include end holes (not shown) at the terminuses 601 .
- FIGS. 7-9 Yet another suitable catheter body shape is shown in FIGS. 7-9 .
- This catheter body 700 has what is referred to as a “tulip” shape.
- the surfaces of the tulip “petals” 701 can be opened into holes 702 .
- the center 703 of the tulip may be a closed end nipple 704 , which captures a pusher rod 705 by which the catheter body 700 is advanced during implantation.
- the pusher rod 705 is extended, the end of the catheter body 700 stretches, collapsing the tulip petals 701 as shown in FIG. 9 .
- the tulip petals 701 expand as shown in FIGS. 7 and 8 .
- This configuration can be shorter then those of FIGS. 1-3 and 5 - 6 because the shape of petals 701 permits holes 702 to have a large surface area compared to holes 102 .
- FIGS. 10-12 Another suitable arrangement for the catheter body that prevents blockage, puncture or loculation is shown in FIGS. 10-12 .
- This embodiment has a short body 1001 terminating in one or more fluid extraction holes 1002 .
- the fluid extraction holes 1002 are surrounded by a spherical cage 1003 that prevents organs, e.g. the bowels 1004 , or debris from blocking the extraction holes 1002 .
- the cage 1003 may have other shapes, but a spherical cage 1003 presents no sharp edges or steps that are likely to cause problems during implantation or removal. Because the cage 1003 surrounds the fluid extraction holes 1002 , the extraction holes 1002 are in a protected region of the catheter body.
- the spherical cage 1003 of this embodiment can be formed of plastic, metal, or any other suitable material. If formed of plastic, the cage 1003 can be molded integrally with the body 1001 of the catheter, in the expanded spherical shape shown in FIGS. 10-12 . If formed of metal, the cage 1003 can be preformed, also in the expanded spherical shape shown in FIGS. 10-12 .
- the metal can be Nitinol or another so-called “memory metal” which can be alternately stowed or deployed, for example by alternate application of room ambient temperature and of the patient's own body heat.
- a metal spherical cage 1003 would also be formed integrally with and molded into the plastic of catheter body 1001 .
- the spherical shape can be collapsed by a pusher rod engaging an end tab 1005 during insertion and extraction.
- the pusher rod is withdrawn completely from the catheter body while the catheter is in situ in a patient's body.
- the proximal end 103 of the catheter body 100 terminates at and is connected for fluid communication to a subcutaneously implantable port 104 .
- the port has a membrane (referred to as a septum) 105 for percutaneous access to the port 104 by a suitably sized extraction needle, e.g., a 14-gauge needle.
- the septum 105 is durable enough to permit at least 50 or more non-coring, self-healing passages by a 14 gauge or larger needle.
- the septum 105 can withstand at least 100 or more, and preferably 200 or more passages.
- the port 104 is constructed of any suitable materials, using any suitable methods.
- the side walls and back wall of the port 104 may be formed of titanium, but other metals or plastics such as acetal homopolymers that are bioinert can be used, for example.
- the top surface is the septum 105 , which may be formed of silicone or other elastomer or plastic.
- the septum 105 of silicone has a surface area of about 1-6 cm 2 and be about 2-4 mm thick.
- the septum 105 may have dimensions of about 1-2 cm by 1-3 cm.
- the walls and septum 105 of the port 104 define a reservoir within that has a low, wide profile to minimize the volume of fluid held in the reservoir, and to maximize the comfort to the patient in whom the port 104 is implanted.
- the port may, without limitation thereto, have overall dimensions of 2 cm by 4 cm by 1 cm.
- Such a port 104 can be implanted in a large pocket formed on the patient's abdominal wall or in another location that avoids interference with patient mobility.
- the catheter body 100 and port 104 may include any suitable connector feature for connecting one to the other. For example, a conventional hub connection (not shown) can be used.
- FIG. 4 shows an alternate embodiment of the invention directed to a multi-septum configuration.
- This multi-septum configuration is useable in combination with any of the catheter body configurations disclosed herein, and any other catheter body configurations.
- the port 401 at the proximal end 103 of the catheter 100 has two chambers 402 , each have a septum 403 , allowing two needles to be placed for more rapid drainage.
- the chambers 402 may be interconnected 404 , and may be connected to a single catheter 100 through a single hub 405 .
- the port 1301 has a ribbed outlet 1302 to which the catheter body 1303 is attached.
- a ribbed outlet 1302 such as shown can be used instead of a conventional hub, such as mentioned above.
- the port outlet 1302 is disposed opposite the septum 1304 , an arrangement also thought to be advantageous in some cases.
- a ribbed outlet 1302 simplifies the construction and assembly of the catheter and port.
- the proximal end 1305 of the catheter body 1303 is simply slipped over the ribbed outlet 1302 , and is held in place by friction between the catheter body 1303 and the ribbed outlet 1302 .
- Placing the ribbed outlet 1302 opposite the septum 1304 is advantageous at least in that the impedance of the structure to fluid flow is reduced relative to placing the outlet to the side of the port, as in the embodiments of FIG. 1-7 . Moreover, implantation can be simplified using this arrangement because the entire assembly is inserted straight into the cavity to be drained, rather than at an angle or along a convoluted path. Yet another advantage of this arrangement is that the catheter is less likely to kink than in a configuration where the catheter body has to transition from a position parallel to the abdominal wall to one perpendicular to the abdominal wall.
- a right-angle outlet 2201 is employed.
- Port 2200 is substantially similar in construction and arrangement to port 104 of FIG. 1 .
- outlet 2201 makes a right-angle bend towards the direction of implantation of a catheter body (not shown), so that kinks or bends are not introduced into the catheter body.
- Outlet 2201 may terminate in a conventional hub (not shown) or ribbed section (not shown) to grip the catheter body.
- the port may also include other useful features.
- the port may include suture loops 1306 by which the port can be secured to tissue in the patient's body.
- the port may have funnel shape to further reduce the impedance of the assembly to fluid flow during extraction.
- the port ( FIG. 1, 104 ) can be accessed through the system 105 by a conventional access needle, for example a 14-gauge needle.
- a removable core access needle 1400 such as shown in FIG. 14 , can be used.
- Such a needle may include a large bore, e.g., 14 gauge, hollow point 1401 .
- the point 1401 may be made of metal, perforated on the sides thereof 1402 , and have a beveled entry edge 1403 to prevent occlusion while in use.
- the point 1401 is affixed to a right-angle end 1404 of a suitable type of tubing 1405 that resists collapse under suction.
- the removable core access needle 1400 has a removable stylete 1406 that resides within the hollow of the point 1401 when not accessing the port, and that is withdrawn when accessing the port. Stylete 1406 removal is facilitated by providing a diaphragm or septum 1407 , through which the stylete 1406 passes and may be inserted or withdrawn.
- bacteriostatic cuff 106 may be provided near the proximal end 103 of the catheter body 100 , so as to prevent inward migration of an infection.
- the cuff 106 promotes fibrous tissue ingrowth.
- Bacteriostatic cuffs of polyester impregnated with bacteriostatic compounds are suitable.
- Tissue collagen acts as a kind of biocompatible glue between the catheter body 100 and port 104 , and the surrounding tissues.
- FIG. 15 a fully integrated, catheterless fluid extraction plug 1500 is shown in FIG. 15 .
- This embodiment combines several features described above in connection with other embodiments, as now described.
- the exemplary catheterless drainage plug 1500 has an expanded port section 1501 and an elongated body section 1502 .
- Any suitable port section shape can be used in combination with any suitable body section shape, including those shown in the other exemplary embodiments.
- the catheterless plug embodiment is advantageous because of its simplicity. Without joints and rough edges that may be found in other designs, there are fewer locations to harbor potentially infectious matter or irritate the implantation site in the patient.
- the device is also less expensive and easier to manufacture than designs using multiple components and joints.
- the devices described herein are all implanted using suitable techniques, including techniques known in the art. One such technique is now described.
- an incision is made in the patient's skin above the location where the device is to be implanted.
- the incision exposes a small area of the underlying cavity wall.
- a hollow needle is inserted through the cavity wall until a “fluid flash” is seen, that is an outflow of fluid from within the body cavity.
- the fluid flash indicates that the needle has been inserted into the desired location.
- a guide wire is inserted through the needle to provide a defined path for the remainder of the devices employed.
- the needle is then withdrawn over the guide wire.
- a sheath and dilator are next inserted, over the guide wire.
- the dilator enlarges the hole through the cavity wall sufficiently to allow a catheter to be inserted. After the dilator has enlarged the hole, it is removed.
- the catheter is then slid over the wire and sheath and through the enlarged hole. Finally the sheath, and optionally the wire, is withdrawn, leaving the catheter in place.
- the bottom of the port could be curved to follow the curve of the patient's abdomen, for patient comfort.
- the port could be “almond-”shaped to leave room for two extraction needles.
- the port shape accommodates a septum large enough to permit rotation of the skin/septum puncture site, so as to avoid skin breakdown as a result of repeated needle punctures. See, for example, FIGS. 16-18 .
- the almond shape would allow room for deep needles, for example needles including side holes. Hollow needles with side holes would permit higher extraction flow rates than hollow needles having only an end hole.
- the eyelets 1306 may be filled with a membrane or not, as desired.
- FIG. 19 shows a helix 1901 combined with a pigtail 1902 .
- FIGS. 20 and 21 show a helix 2001 combined with a straight section 2002 .
- the geometry is such that it allows straightening followed by self-coiling or bunching, for implantation.
Landscapes
- Health & Medical Sciences (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Otolaryngology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- External Artificial Organs (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
A catheter comprises a catheter body having a wall defining a lumen therein and having plural holes defined through the wall in a pattern which prevents loculation, migration and blockage of a fluid flow through the lumen, the catheter body having a tissue-puncture resistant shape; and a port having a reservoir capable of multiple needle accesses. The catheter is useful for draining fluids from a patient's body cavity, for example the peritoneal cavity.
Description
- This application is a divisional application claiming the benefit under 35 U.S.C. §§ 120 and 121 of U.S. application Ser. No. 10/172,160 filed on Jun. 14, 2002, which claims domestic priority under 35 U.S.C. § 119(e) to provisional Patent Application No. 60/370,558 filed Apr. 4, 2002, all of which are hereby incorporated by reference.
- The present invention relates to devices that permit repeated access to the peritoneal or thoracic cavities. More particularly, the invention relates to a peritoneal and thoracic cavity port catheter.
- Certain medical conditions (e.g., ovarian cancer) are treated by infusing a body cavity with a fluid medical preparation through a catheter with one or more infusion holes at a distal end thereof and with an access port or other such device at a proximal end thereof.
- In the case of ovarian cancer, the radioactive isotope P32 is administered in a fluid medium infused into the peritoneal cavity, in which the patient's ovaries are located. When ovarian cancer metastasizes or spreads from the ovaries, the cancer cells simply fall off of the ovaries and spread around the peritoneal cavity, but generally do not enter the blood stream. Therefore, a therapy, which floods the peritoneal cavity with P32, is effective, without unnecessarily exposing the patient to radioactivity in undesired areas. However, ovarian cancer cells, having somewhat defective cell membranes, leak fluids, called ascites, into the peritoneal cavity. Treatment of ovarian cancer includes removal of this fluid. The procedure for doing so typically uses the same catheter through which the infusion is performed, and takes about four hours, requiring hospitalization, and is performed about once a week.
- Because conventional infusion catheters are optimized for infusion, they can only be used to remove fluids from the peritoneal cavity very slowly, resulting in the long, periodic hospitalization for ovarian cancer patients.
- There are similar needs under some circumstances to have access to the thoracic cavity or other body cavities, and current devices for obtaining such are similarly limited.
- In accordance with aspects of an embodiment of the invention, there may be provided a catheter, comprising a catheter body having a wall defining a lumen therein and having plural holes defined through the wall in a pattern which prevents loculation, migration and blockage of a fluid flow through the lumen, the catheter body having a tissue-puncture resistant shape; and a port having a reservoir capable of multiple needle accesses.
- In the figures, in which like reference designations indicate like elements:
-
FIG. 1 is a top view of a catheter and port embodying aspects of the invention; -
FIG. 2 is a cross sectional detail view of the catheter ofFIG. 1 , taken along line 1-1; -
FIG. 3 is a perspective view of the catheter ofFIG. 1 ; -
FIG. 4 is a top view of an alternate port configuration embodying aspects of the invention; -
FIG. 5 is a top view of an alternate catheter configuration embodying aspects of the invention; -
FIG. 6 is a top view of yet another alternate catheter configuration embodying aspects of the invention; -
FIG. 7 is a top view of an alternate catheter and port configuration embodying aspects of the invention; -
FIG. 8 is an end view of the catheter ofFIG. 7 ; -
FIG. 9 is a top view of the catheter ofFIGS. 7-8 , extended by a pusher rod shown in phantom; -
FIG. 10 shows a cross section of a patient's peritoneal cavity, into whose wall another configuration of port and catheter has been implanted; -
FIG. 11 is a side view of the distal end of the catheter body ofFIG. 10 ; -
FIG. 12 is an end view of the catheter body ofFIG. 10 ; -
FIG. 13 is a perspective view of the port and catheter connection of the embodiment ofFIG. 10 ; -
FIG. 14 is a cross-sectional side view of a removable core access needle used in various embodiments; -
FIG. 15 is a side view of a catheterless plug; -
FIGS. 16, 17 and 18 are side, top and front views, respectively, of an alternate port design; -
FIG. 19 is a side view of a combined catheter shape; -
FIGS. 20 and 21 are end and side views, respectively, of an alternate combined catheter shape; and -
FIGS. 22 and 23 are side and top views, respectively, of a port design having a right-angle outlet. - In accordance with some embodiments of the present invention, a method and apparatus is provided for removal of fluids from a patient's body, for example draining fluids from a body cavity between multiple drug infusion operations (e.g., during the entire duration of treatment).
- Embodiments of aspects of the invention may include a catheter or a catheterless plug having a catheter body and an access port, and a method of extracting fluid from a body cavity. As explained more fully below, the catheterless plug has a body resembling a catheter body, but which can comprise a fully integrated unit. References below to the catheter body apply to the body of the catheterless plug, as well, except where differences are explicitly mentioned.
- The catheter body should preferably have a shape that is unlikely to undesirably puncture or injure tissue or organs encountered in or about the body cavity to be drained. The shape of the catheter body, together with the placement of one or more fluid extraction holes in a wall of the catheter body should preferably be such as to avoid the formation of pockets (referred to by those skilled in this art as loculation) and/or to avoid creating a fluid flow that would cause migration of the catheter body, or of tissue or debris, that could block the extraction holes. For example, the extraction holes can be positioned in a protected region of the catheter body, as described below.
- The catheter port should preferably be implantable subcutaneously, and/or capable of sufficient extraction needle passages to complete a course of treatment without replacement.
- The invention is now illustrated in further detail with reference to some embodiments thereof. In the following description the illustrative example of extracting fluid from the peritoneal cavity is used. However, it should be understood that the invention may be employed in connection with treatments requiring the extraction of fluid from the thoracic cavity or another body cavity.
- One aspect of the invention is illustrated in connection with a
catheter 10 including a catheter body 100 (FIGS. 1-3 ) having a lumen (FIG. 2, 200 ) that may be closed off at thedistal end 101, i.e., having no end hole. This embodiment includesplural holes 102 covering a combined surface area suitable for withdrawing fluid, substantially without clogging. Thus, when thecatheter 10 is used to extract fluid from the peritoneal cavity, there is no large suction through a dominant single point which could attract occluding masses to migrate to the dominant single point or could attract the catheter itself to migrate into a position where a dominant single point is occluded. Optionally, in another embodiment, an end hole can be provided at thedistal end 101 ofcatheter body 100, together with one or moreother holes 102, provided neither ahole 102 nor the optional end hole contributes such a surface area, and consequently large fluid flow, as to induce loculation or migration of thecatheter body 100. - In order to provide more room for
holes 102, thecatheter body 100 of this embodiment is quite long. One danger inherent in implanting acatheter 10 in many body cavities is the risk of perforating or puncturing an organ, membrane, or other tissue unintentionally. The risk is especially large when along catheter body 100 is implanted into a closed cavity such as the peritoneal cavity, with the expectation that the catheter will bunch up like spaghetti. - In the embodiment of
FIGS. 1-3 , thecatheter body 100 is a self-coiling type to facilitate insertion of such a relatively long catheter into the body. This may be achieved by means known to the skilled practitioner such as molding thecatheter body 100 in a desired coil configuration, molding thecatheter body 100 on a coiled strength member such as a wire, etc. The coil may be flat, a straight-sided helix, a conical helix, etc. - The embodiment of
FIGS. 1-3 employs a flat coil pigtail configuration, although other coil configurations, as well as configurations that avoid perforation or puncture using other shapes, as explained below, are possible. - As stated above, the
holes 102 should be positioned to avoid contact with adjacent tissues or occluding masses. Theholes 102 of this embodiment are positioned on theinner curve 107 of the coil so as to avoid contact between theholes 102 and adjacent tissues. Theouter curve 108 and thesides 109 can be devoid of holes. Thus, theholes 102 are in a protected region of the catheter body. As used herein, “inner curve” refers to that part of the surface of a coil-shapedcatheter body 100 facing a central axis of the coil of thecatheter body 100. Also as used herein, “outer curve” is that part of the surface of the coil-shapedcatheter body 100 facing away from a central axis of the coil of thecatheter body 100. Finally as used herein, “sides” are surfaces of the coil-shapedcatheter body 100 adjacent to both theinner curve 107 andouter curve 108 and joining them. - As mentioned, other shapes can also avoid puncturing adjacent tissues, organs and membranes, while distributing
holes 102 to prevent loculation, migration or occlusion. As shown inFIG. 5 , an alternate embodiment of acatheter 500 has acatheter body 501 with a shape such as a simple helix or corkscrew, that avoids punctures.Holes 102 are disposed on theinner curve 502 of thecatheter body 501 to avoid contact between theholes 102 and adjacent tissues. Again, theholes 102 are located in a protected region of the catheter body. Thiscatheter 500 and thecatheter 10 ofFIGS. 1-3 can optionally include an end hole (not shown) at thedistal end 503 provided the area of the end hole is properly balanced against the areas of theholes 102. - Another catheter body shape possessing desirable characteristics of avoiding punctures, loculation, migration and occlusion is shown in
FIG. 6 . In this example,catheter body 600 has a T-bar shape. Theterminuses 601 may be closed or may optionally include end holes (not shown) at theterminuses 601. - Yet another suitable catheter body shape is shown in
FIGS. 7-9 . Thiscatheter body 700 has what is referred to as a “tulip” shape. The surfaces of the tulip “petals” 701 can be opened intoholes 702. Thecenter 703 of the tulip may be aclosed end nipple 704, which captures apusher rod 705 by which thecatheter body 700 is advanced during implantation. When thepusher rod 705 is extended, the end of thecatheter body 700 stretches, collapsing thetulip petals 701 as shown inFIG. 9 . When thepusher rod 705 is withdrawn, after implantation, thetulip petals 701 expand as shown inFIGS. 7 and 8 . This configuration can be shorter then those ofFIGS. 1-3 and 5-6 because the shape ofpetals 701permits holes 702 to have a large surface area compared toholes 102. - Another suitable arrangement for the catheter body that prevents blockage, puncture or loculation is shown in
FIGS. 10-12 . This embodiment has ashort body 1001 terminating in one or more fluid extraction holes 1002. Thefluid extraction holes 1002 are surrounded by aspherical cage 1003 that prevents organs, e.g. thebowels 1004, or debris from blocking the extraction holes 1002. Thecage 1003 may have other shapes, but aspherical cage 1003 presents no sharp edges or steps that are likely to cause problems during implantation or removal. Because thecage 1003 surrounds thefluid extraction holes 1002, theextraction holes 1002 are in a protected region of the catheter body. - The
spherical cage 1003 of this embodiment can be formed of plastic, metal, or any other suitable material. If formed of plastic, thecage 1003 can be molded integrally with thebody 1001 of the catheter, in the expanded spherical shape shown inFIGS. 10-12 . If formed of metal, thecage 1003 can be preformed, also in the expanded spherical shape shown inFIGS. 10-12 . The metal can be Nitinol or another so-called “memory metal” which can be alternately stowed or deployed, for example by alternate application of room ambient temperature and of the patient's own body heat. A metalspherical cage 1003 would also be formed integrally with and molded into the plastic ofcatheter body 1001. In an alternative method of stowing and deploying the device, as in the case of the tulip design described above in connection withFIGS. 7-9 , the spherical shape can be collapsed by a pusher rod engaging anend tab 1005 during insertion and extraction. The pusher rod is withdrawn completely from the catheter body while the catheter is in situ in a patient's body. - The catheter body (
FIG. 1, 100 ;FIG. 5, 501 ;FIG. 6, 600 ,FIG. 7, 700 ,FIG. 10, 1001 ) may be constructed of any suitable materials, using any suitable methods.Holes - Ports usable in connection with the catheter bodies described above are now described.
- In the embodiment of
FIG. 1 , theproximal end 103 of thecatheter body 100 terminates at and is connected for fluid communication to a subcutaneouslyimplantable port 104. The port has a membrane (referred to as a septum) 105 for percutaneous access to theport 104 by a suitably sized extraction needle, e.g., a 14-gauge needle. In one embodiment, theseptum 105 is durable enough to permit at least 50 or more non-coring, self-healing passages by a 14 gauge or larger needle. In other embodiments, theseptum 105 can withstand at least 100 or more, and preferably 200 or more passages. - The
port 104 is constructed of any suitable materials, using any suitable methods. In one embodiment, the side walls and back wall of theport 104 may be formed of titanium, but other metals or plastics such as acetal homopolymers that are bioinert can be used, for example. The top surface is theseptum 105, which may be formed of silicone or other elastomer or plastic. In embodiments capable of withstanding 200 passages by a 14-gauge needle, theseptum 105 of silicone has a surface area of about 1-6 cm2 and be about 2-4 mm thick. Typically, but without limitation thereto, theseptum 105 may have dimensions of about 1-2 cm by 1-3 cm. - The walls and
septum 105 of theport 104 define a reservoir within that has a low, wide profile to minimize the volume of fluid held in the reservoir, and to maximize the comfort to the patient in whom theport 104 is implanted. The port may, without limitation thereto, have overall dimensions of 2 cm by 4 cm by 1 cm. Such aport 104 can be implanted in a large pocket formed on the patient's abdominal wall or in another location that avoids interference with patient mobility. Thecatheter body 100 andport 104 may include any suitable connector feature for connecting one to the other. For example, a conventional hub connection (not shown) can be used. -
FIG. 4 shows an alternate embodiment of the invention directed to a multi-septum configuration. This multi-septum configuration is useable in combination with any of the catheter body configurations disclosed herein, and any other catheter body configurations. In the embodiment ofFIG. 4 , theport 401 at theproximal end 103 of thecatheter 100 has twochambers 402, each have aseptum 403, allowing two needles to be placed for more rapid drainage. Thechambers 402 may be interconnected 404, and may be connected to asingle catheter 100 through asingle hub 405. - In the alternative embodiment shown in
FIG. 13 , theport 1301 has a ribbedoutlet 1302 to which thecatheter body 1303 is attached. Aribbed outlet 1302 such as shown can be used instead of a conventional hub, such as mentioned above. In this embodiment, theport outlet 1302 is disposed opposite theseptum 1304, an arrangement also thought to be advantageous in some cases. - Use of a
ribbed outlet 1302 simplifies the construction and assembly of the catheter and port. Theproximal end 1305 of thecatheter body 1303 is simply slipped over theribbed outlet 1302, and is held in place by friction between thecatheter body 1303 and theribbed outlet 1302. - Placing the
ribbed outlet 1302 opposite theseptum 1304 is advantageous at least in that the impedance of the structure to fluid flow is reduced relative to placing the outlet to the side of the port, as in the embodiments ofFIG. 1-7 . Moreover, implantation can be simplified using this arrangement because the entire assembly is inserted straight into the cavity to be drained, rather than at an angle or along a convoluted path. Yet another advantage of this arrangement is that the catheter is less likely to kink than in a configuration where the catheter body has to transition from a position parallel to the abdominal wall to one perpendicular to the abdominal wall. - In another alternative embodiment, shown in
FIGS. 22 and 23 , exhibiting advantages similar to those of the embodiment ofFIG. 13 , a right-angle outlet 2201 is employed.Port 2200 is substantially similar in construction and arrangement to port 104 ofFIG. 1 . However,outlet 2201 makes a right-angle bend towards the direction of implantation of a catheter body (not shown), so that kinks or bends are not introduced into the catheter body.Outlet 2201 may terminate in a conventional hub (not shown) or ribbed section (not shown) to grip the catheter body. - The port may also include other useful features. For example, the port may include
suture loops 1306 by which the port can be secured to tissue in the patient's body. The port may have funnel shape to further reduce the impedance of the assembly to fluid flow during extraction. - As identified above, the port (
FIG. 1, 104 ) can be accessed through thesystem 105 by a conventional access needle, for example a 14-gauge needle. Alternatively, a removablecore access needle 1400, such as shown inFIG. 14 , can be used. Such a needle may include a large bore, e.g., 14 gauge,hollow point 1401. Thepoint 1401 may be made of metal, perforated on the sides thereof 1402, and have abeveled entry edge 1403 to prevent occlusion while in use. Thepoint 1401 is affixed to a right-angle end 1404 of a suitable type oftubing 1405 that resists collapse under suction. In order to control access through such a needle, and to prevent coring of the septum (FIG. 1, 105 ) during insertion, the removablecore access needle 1400 has aremovable stylete 1406 that resides within the hollow of thepoint 1401 when not accessing the port, and that is withdrawn when accessing the port.Stylete 1406 removal is facilitated by providing a diaphragm orseptum 1407, through which thestylete 1406 passes and may be inserted or withdrawn. - It has been found that no cuff, as is often conventionally provided, is necessary. However, if desired, a
bacteriostatic cuff 106 may provided near theproximal end 103 of thecatheter body 100, so as to prevent inward migration of an infection. Thecuff 106 promotes fibrous tissue ingrowth. Bacteriostatic cuffs of polyester impregnated with bacteriostatic compounds are suitable. - Leaking around the catheter can be prevented by use of a tissue collagen injection at one or more sites around the implanted system. Tissue collagen acts as a kind of biocompatible glue between the
catheter body 100 andport 104, and the surrounding tissues. - In yet another embodiment, a fully integrated, catheterless
fluid extraction plug 1500 is shown inFIG. 15 . This embodiment combines several features described above in connection with other embodiments, as now described. - The exemplary
catheterless drainage plug 1500 has an expandedport section 1501 and anelongated body section 1502. Any suitable port section shape can be used in combination with any suitable body section shape, including those shown in the other exemplary embodiments. - The catheterless plug embodiment is advantageous because of its simplicity. Without joints and rough edges that may be found in other designs, there are fewer locations to harbor potentially infectious matter or irritate the implantation site in the patient. The device is also less expensive and easier to manufacture than designs using multiple components and joints.
- The devices described herein are all implanted using suitable techniques, including techniques known in the art. One such technique is now described.
- First an incision is made in the patient's skin above the location where the device is to be implanted. The incision exposes a small area of the underlying cavity wall. A hollow needle is inserted through the cavity wall until a “fluid flash” is seen, that is an outflow of fluid from within the body cavity. The fluid flash indicates that the needle has been inserted into the desired location. Next, a guide wire is inserted through the needle to provide a defined path for the remainder of the devices employed. The needle is then withdrawn over the guide wire. A sheath and dilator are next inserted, over the guide wire. The dilator enlarges the hole through the cavity wall sufficiently to allow a catheter to be inserted. After the dilator has enlarged the hole, it is removed. The catheter is then slid over the wire and sheath and through the enlarged hole. Finally the sheath, and optionally the wire, is withdrawn, leaving the catheter in place.
- Various modifications to the port could now be evident to the skilled artisan. For example, the bottom of the port could be curved to follow the curve of the patient's abdomen, for patient comfort. Alternatively, the port could be “almond-”shaped to leave room for two extraction needles. Preferably, the port shape accommodates a septum large enough to permit rotation of the skin/septum puncture site, so as to avoid skin breakdown as a result of repeated needle punctures. See, for example,
FIGS. 16-18 . The almond shape would allow room for deep needles, for example needles including side holes. Hollow needles with side holes would permit higher extraction flow rates than hollow needles having only an end hole. Theeyelets 1306 may be filled with a membrane or not, as desired. - According to yet other variations, the shapes and features described above, and others, can be combined, as for example as shown in
FIGS. 19-21 .FIG. 19 shows ahelix 1901 combined with apigtail 1902.FIGS. 20 and 21 show ahelix 2001 combined with astraight section 2002. In each case, the geometry is such that it allows straightening followed by self-coiling or bunching, for implantation. - The present invention has now been described in connection with a number of specific embodiments thereof. However, numerous modifications, which are contemplated as falling within the scope of the present invention, should now be apparent to those skilled in the art. Therefore, it is intended that the scope of the present invention be limited only by the scope of the claims appended hereto.
Claims (15)
1. A catheter for removing fluid from a body cavity, comprising:
a catheter body extendible substantially within the body cavity having a wall defining a lumen therein and having at least one hole defined in the catheter body in a location that is within the body cavity when implanted, and which in combination with a shape of the catheter body prevents loculation, migration and blockage of a fluid flow through the lumen when the fluid flow is induced in a direction defined as running from a distal end to a proximal end thereof, the catheter body having a tissue-puncture resistant shape; and
a port having on a first surface a septum capable of multiple needle accesses, and having on a second surface an outlet in communication with the catheter body and arranged so the catheter body extends substantially without bends in a direction perpendicular to the first surface, into the body cavity.
2. The catheter of claim 1 , wherein the plural holes are located in a protected region of the catheter body.
3. The catheter of claim 2 , having a pigtail coil shape.
4. The catheter of claim 3 , wherein the plural holes are located in a protected region defined by an inner curve of the pigtail coil.
5. The catheter of claim 2 , having a helix coil shape.
6. The catheter of claim 5 , wherein the plural holes are located in a protected region defined by an inner curve of the helix coil.
7. The catheter of claim 2 , having a T-bar shape.
8. The catheter of claim 7 , wherein the plural holes are located in a protected region defined adjacent an angle between a stem and a crossbar of the T-bar.
9. The catheter of claim 1 , having a tulip shape.
10. The catheter of claim 9 , wherein the plural holes are located on a broad surface of a petal of the tulip.
11. The catheter of claim 10 , the tulip collapsible when advanced by a pusher rod.
12. The catheter of claim 1 , further comprising:
another port coupled to the first port and to the body of the catheter for fluid communication therewith.
13. The catheter of claim 1 , further comprising:
a cage surrounding at least part of the catheter body including the plural holes.
14. The catheter of claim 13 , wherein the cage is integral with the catheter body.
15. The catheter of claim 13 , wherein the cage is memory metal.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/230,048 US20060015089A1 (en) | 2002-04-04 | 2005-09-19 | Catheter and method of fluid removal from a body cavity |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37055802P | 2002-04-04 | 2002-04-04 | |
US10/172,160 US7048729B2 (en) | 2002-04-04 | 2002-06-14 | Catheter and method of fluid removal from a body cavity |
US11/230,048 US20060015089A1 (en) | 2002-04-04 | 2005-09-19 | Catheter and method of fluid removal from a body cavity |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/172,160 Division US7048729B2 (en) | 2002-04-04 | 2002-06-14 | Catheter and method of fluid removal from a body cavity |
Publications (1)
Publication Number | Publication Date |
---|---|
US20060015089A1 true US20060015089A1 (en) | 2006-01-19 |
Family
ID=28677938
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/172,160 Expired - Fee Related US7048729B2 (en) | 2002-04-04 | 2002-06-14 | Catheter and method of fluid removal from a body cavity |
US11/230,048 Abandoned US20060015089A1 (en) | 2002-04-04 | 2005-09-19 | Catheter and method of fluid removal from a body cavity |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/172,160 Expired - Fee Related US7048729B2 (en) | 2002-04-04 | 2002-06-14 | Catheter and method of fluid removal from a body cavity |
Country Status (1)
Country | Link |
---|---|
US (2) | US7048729B2 (en) |
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110144559A1 (en) * | 2009-06-16 | 2011-06-16 | Khalid Lafdi | Medical drainage devices with carbon-based structures for inhibiting growth of fibroblasts |
US20130085468A1 (en) * | 2011-10-03 | 2013-04-04 | Yuri Buydenok | Catheter with body wall separator |
USD679804S1 (en) | 2011-09-22 | 2013-04-09 | Vital 5, Llc | Catheter |
GB2496369A (en) * | 2011-10-17 | 2013-05-15 | Miles Charles Deholm Dalby | Catheter for delivering radiopaque material |
WO2013111057A1 (en) * | 2012-01-24 | 2013-08-01 | Kimberly-Clark Worldwide, Inc. | Drainage catheter system with cuff |
WO2014153789A1 (en) * | 2013-03-29 | 2014-10-02 | 广东百合医疗科技股份有限公司 | Minimally invasive thoracic cavity drainage tube and drainage surgical instrument satisfying anthropotomical characteristics |
US20150196741A1 (en) * | 2014-01-15 | 2015-07-16 | Tufts Medical Center, Inc. | Endovascular cerebrospinal fluid shunt |
US9265913B2 (en) | 2010-09-22 | 2016-02-23 | Vital 5, Llc | Catheter assembly |
US9402973B2 (en) | 2007-07-06 | 2016-08-02 | Vital 5, Llc | Constrained fluid delivery device |
US9446224B2 (en) | 2010-09-22 | 2016-09-20 | Vital 5, L.L.C. | Barrier catheter |
US9545505B2 (en) | 2014-10-31 | 2017-01-17 | Cerevasc, Llc | Methods and systems for treating hydrocephalus |
US9737697B2 (en) | 2009-01-29 | 2017-08-22 | Tufts Medical Center, Inc. | Endovascular cerebrospinal fluid shunt |
WO2018039250A1 (en) * | 2016-08-24 | 2018-03-01 | Inpress Technologies, Inc. | Uterine hemorrhage controlling system and method |
US10064651B2 (en) | 2012-03-15 | 2018-09-04 | Inpress Technologies, Inc. | Uterine hemorrhage controlling system and method |
JP2018196754A (en) * | 2015-07-20 | 2018-12-13 | ストラタカ システムズ リミテッド | Urinary duct, bladder catheter, and method for inducing negative pressure for increasing kidney perfusion |
US20190009054A1 (en) * | 2017-07-05 | 2019-01-10 | Duke University | Drainage or infusion catheter and method of use |
US10272230B2 (en) | 2015-10-30 | 2019-04-30 | Cerevasc, Llc | Systems and methods for treating hydrocephalus |
RU194110U1 (en) * | 2019-04-30 | 2019-11-28 | Федеральное Государственное Бюджетное Образовательное Учреждение Высшего Образования "Тюменский Государственный Медицинский Университет" Министерства Здравоохранения Российской Федерации | Hepatic drainage |
US20210030590A1 (en) * | 2018-02-22 | 2021-02-04 | Ivantis, Inc. | Ocular implant and delivery system |
US11013900B2 (en) | 2018-03-08 | 2021-05-25 | CereVasc, Inc. | Systems and methods for minimally invasive drug delivery to a subarachnoid space |
US11278708B2 (en) | 2014-01-15 | 2022-03-22 | Tufts Medical Center, Inc. | Endovascular cerebrospinal fluid shunt |
US11471583B2 (en) | 2015-07-20 | 2022-10-18 | Roivios Limited | Method of removing excess fluid from a patient with hemodilution |
US11541205B2 (en) | 2015-07-20 | 2023-01-03 | Roivios Limited | Coated urinary catheter or ureteral stent and method |
US11612714B2 (en) | 2015-07-20 | 2023-03-28 | Roivios Limited | Systems and methods for inducing negative pressure in a portion of a urinary tract of a patient |
US11752300B2 (en) | 2015-07-20 | 2023-09-12 | Roivios Limited | Catheter device and method for inducing negative pressure in a patient's bladder |
US11896785B2 (en) | 2015-07-20 | 2024-02-13 | Roivios Limited | Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion |
US11918754B2 (en) | 2015-07-20 | 2024-03-05 | Roivios Limited | Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8177762B2 (en) | 1998-12-07 | 2012-05-15 | C. R. Bard, Inc. | Septum including at least one identifiable feature, access ports including same, and related methods |
US7326196B2 (en) * | 2002-10-14 | 2008-02-05 | Breg, Inc. | Catheter assemblies for controlled movement of fluid |
US7947022B2 (en) * | 2005-03-04 | 2011-05-24 | C. R. Bard, Inc. | Access port identification systems and methods |
US8029482B2 (en) | 2005-03-04 | 2011-10-04 | C. R. Bard, Inc. | Systems and methods for radiographically identifying an access port |
EP1858565B1 (en) | 2005-03-04 | 2021-08-11 | C.R. Bard, Inc. | Access port identification systems and methods |
US9474888B2 (en) | 2005-03-04 | 2016-10-25 | C. R. Bard, Inc. | Implantable access port including a sandwiched radiopaque insert |
US20060217668A1 (en) * | 2005-03-22 | 2006-09-28 | Schulze Dale R | Method of implanting a subcutaneous injection port having stabilizing elements |
US8147455B2 (en) | 2005-04-27 | 2012-04-03 | C. R. Bard, Inc. | Infusion apparatuses and methods of use |
US10307581B2 (en) | 2005-04-27 | 2019-06-04 | C. R. Bard, Inc. | Reinforced septum for an implantable medical device |
EP3884989B1 (en) | 2005-04-27 | 2022-07-13 | C. R. Bard, Inc. | Vascular access port |
US9642986B2 (en) | 2006-11-08 | 2017-05-09 | C. R. Bard, Inc. | Resource information key for an insertable medical device |
US9265912B2 (en) | 2006-11-08 | 2016-02-23 | C. R. Bard, Inc. | Indicia informative of characteristics of insertable medical devices |
WO2008157435A1 (en) * | 2007-06-14 | 2008-12-24 | Northstar Neuroscience, Nc. | Microdevice-based electrode assemblies and associated neural stimulation systems, devices, and methods |
EP3269417A1 (en) | 2007-06-20 | 2018-01-17 | Medical Components, Inc. | Implantable access port with molded and/or radiopaque indicia |
US9610432B2 (en) | 2007-07-19 | 2017-04-04 | Innovative Medical Devices, Llc | Venous access port assembly with X-ray discernable indicia |
ES2650800T3 (en) | 2007-07-19 | 2018-01-22 | Medical Components, Inc. | Venous reservoir set with X-ray discernible indications |
US9579496B2 (en) | 2007-11-07 | 2017-02-28 | C. R. Bard, Inc. | Radiopaque and septum-based indicators for a multi-lumen implantable port |
EP2093011A1 (en) * | 2008-02-22 | 2009-08-26 | National University of Ireland Galway | A method and apparatus for detecting hole breakthrough in a laser drilling process, using an optical fibre |
CN102271737B (en) | 2008-10-31 | 2016-02-17 | C·R·巴德股份有限公司 | For providing the subcutaneous entry port entered of patient |
US11890443B2 (en) | 2008-11-13 | 2024-02-06 | C. R. Bard, Inc. | Implantable medical devices including septum-based indicators |
US8932271B2 (en) | 2008-11-13 | 2015-01-13 | C. R. Bard, Inc. | Implantable medical devices including septum-based indicators |
WO2011005847A1 (en) | 2009-07-07 | 2011-01-13 | C. R. Bard, Inc. | Extensible internal bolster for a medical device |
ES2695907T3 (en) | 2009-11-17 | 2019-01-11 | Bard Inc C R | Overmolded access port that includes anchoring and identification features |
USD682416S1 (en) | 2010-12-30 | 2013-05-14 | C. R. Bard, Inc. | Implantable access port |
USD676955S1 (en) | 2010-12-30 | 2013-02-26 | C. R. Bard, Inc. | Implantable access port |
US9550014B2 (en) * | 2012-03-15 | 2017-01-24 | Inpress Technologies, Inc. | Postpartum uterine contractile apparatus and method |
US20140228801A1 (en) * | 2013-02-12 | 2014-08-14 | Gary Keeling | Body cavity drainage device and methods for using the same |
US20140350518A1 (en) | 2013-05-23 | 2014-11-27 | Allergan, Inc. | Syringe extrusion accessory |
US10029048B2 (en) | 2014-05-13 | 2018-07-24 | Allergan, Inc. | High force injection devices |
US10226585B2 (en) | 2014-10-01 | 2019-03-12 | Allergan, Inc. | Devices for injection and dosing |
BR112017019272A2 (en) | 2015-03-10 | 2018-05-02 | Allergan Pharmaceuticals Holdings Ireland Unlimited Company | multiple needle injector |
US11229771B2 (en) | 2015-07-20 | 2022-01-25 | Roivios Limited | Percutaneous ureteral catheter |
US10765834B2 (en) | 2015-07-20 | 2020-09-08 | Strataca Systems Limited | Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion |
US11040180B2 (en) * | 2015-07-20 | 2021-06-22 | Strataca Systems Limited | Systems, kits and methods for inducing negative pressure to increase renal function |
DK3552652T3 (en) | 2015-08-18 | 2021-07-12 | Braun Melsungen Ag | CATHETER FACILITIES WITH VALVES |
CA3020146A1 (en) | 2016-04-08 | 2017-10-12 | Allergan, Inc. | Aspiration and injection device |
USD867582S1 (en) | 2017-03-24 | 2019-11-19 | Allergan, Inc. | Syringe device |
WO2018218084A2 (en) * | 2017-05-26 | 2018-11-29 | Pan Medical Us Corporation | Kyphoplasty device and method |
US10779870B2 (en) * | 2017-10-16 | 2020-09-22 | Medtronic Holding Company Sarl | Curved inflatable bone tamp with variable wall thickness |
WO2020127328A1 (en) | 2018-12-17 | 2020-06-25 | B. Braun Melsungen Ag | Over-the-needle catheter assemblies and related manufacturing method |
WO2021146589A1 (en) * | 2020-01-16 | 2021-07-22 | Nxt Biomedical, Llc | Lymphatic access, drainage, and shunting |
Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3602228A (en) * | 1968-10-03 | 1971-08-31 | Bard Inc C R | Funnel unit for plastic catheter |
US3680562A (en) * | 1971-04-26 | 1972-08-01 | Becton Dickinson Co | Surgical drainage apparatus for bladder |
US4802885A (en) * | 1986-06-17 | 1989-02-07 | Medical Engineering Corporation | Self sealing subcutaneous infusion and withdrawal device |
US4880414A (en) * | 1987-12-31 | 1989-11-14 | Pharmacia Nu Tech | Catheter attachment system |
US4963133A (en) * | 1987-12-31 | 1990-10-16 | Pharmacia Deltec, Inc. | Catheter attachment system |
US4986814A (en) * | 1988-06-13 | 1991-01-22 | Indianapolis Center For Advanced Research | One-punch catheter |
US5085644A (en) * | 1990-04-02 | 1992-02-04 | Pudenz-Schulte Medical Research Corporation | Sterilizable medication infusion device with dose recharge restriction |
US5112303A (en) * | 1991-05-02 | 1992-05-12 | Pudenz-Schulte Medical Research Corporation | Tumor access device and method for delivering medication into a body cavity |
US5800390A (en) * | 1991-05-24 | 1998-09-01 | Sumitomo Pharmaceuticals Company, Limited | Equipment for intracerebral administration of preparations |
US5931829A (en) * | 1997-01-21 | 1999-08-03 | Vasca, Inc. | Methods and systems for establishing vascular access |
US6546280B2 (en) * | 1996-06-18 | 2003-04-08 | Cook Incorporated | Indwelling catheter |
US6569150B2 (en) * | 2000-04-11 | 2003-05-27 | Scimed Life Systems, Inc. | Reinforced retention structures |
US6656146B1 (en) * | 1995-11-07 | 2003-12-02 | Scimed Life Systems, Inc. | Medical device with tail(s) |
US6673060B1 (en) * | 2000-04-25 | 2004-01-06 | Manan Medical Products, Inc. | Drainage catheter and method for forming same |
US20040049157A1 (en) * | 2001-09-13 | 2004-03-11 | Michael Plishka | Paracentesis device having multiple detachable components |
-
2002
- 2002-06-14 US US10/172,160 patent/US7048729B2/en not_active Expired - Fee Related
-
2005
- 2005-09-19 US US11/230,048 patent/US20060015089A1/en not_active Abandoned
Patent Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3602228A (en) * | 1968-10-03 | 1971-08-31 | Bard Inc C R | Funnel unit for plastic catheter |
US3680562A (en) * | 1971-04-26 | 1972-08-01 | Becton Dickinson Co | Surgical drainage apparatus for bladder |
US4802885A (en) * | 1986-06-17 | 1989-02-07 | Medical Engineering Corporation | Self sealing subcutaneous infusion and withdrawal device |
US4880414A (en) * | 1987-12-31 | 1989-11-14 | Pharmacia Nu Tech | Catheter attachment system |
US4963133A (en) * | 1987-12-31 | 1990-10-16 | Pharmacia Deltec, Inc. | Catheter attachment system |
US4986814A (en) * | 1988-06-13 | 1991-01-22 | Indianapolis Center For Advanced Research | One-punch catheter |
US5085644A (en) * | 1990-04-02 | 1992-02-04 | Pudenz-Schulte Medical Research Corporation | Sterilizable medication infusion device with dose recharge restriction |
US5112303A (en) * | 1991-05-02 | 1992-05-12 | Pudenz-Schulte Medical Research Corporation | Tumor access device and method for delivering medication into a body cavity |
US5800390A (en) * | 1991-05-24 | 1998-09-01 | Sumitomo Pharmaceuticals Company, Limited | Equipment for intracerebral administration of preparations |
US6656146B1 (en) * | 1995-11-07 | 2003-12-02 | Scimed Life Systems, Inc. | Medical device with tail(s) |
US6546280B2 (en) * | 1996-06-18 | 2003-04-08 | Cook Incorporated | Indwelling catheter |
US5931829A (en) * | 1997-01-21 | 1999-08-03 | Vasca, Inc. | Methods and systems for establishing vascular access |
US6569150B2 (en) * | 2000-04-11 | 2003-05-27 | Scimed Life Systems, Inc. | Reinforced retention structures |
US6673060B1 (en) * | 2000-04-25 | 2004-01-06 | Manan Medical Products, Inc. | Drainage catheter and method for forming same |
US20040049157A1 (en) * | 2001-09-13 | 2004-03-11 | Michael Plishka | Paracentesis device having multiple detachable components |
Cited By (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9402973B2 (en) | 2007-07-06 | 2016-08-02 | Vital 5, Llc | Constrained fluid delivery device |
US10112036B2 (en) | 2009-01-29 | 2018-10-30 | Tufts Medical Center, Inc. | Endovascular cerebrospinal fluid shunt |
US9737697B2 (en) | 2009-01-29 | 2017-08-22 | Tufts Medical Center, Inc. | Endovascular cerebrospinal fluid shunt |
US20110144559A1 (en) * | 2009-06-16 | 2011-06-16 | Khalid Lafdi | Medical drainage devices with carbon-based structures for inhibiting growth of fibroblasts |
US10137226B2 (en) * | 2009-06-16 | 2018-11-27 | Mobius Therapeutics, Llc | Medical drainage devices with carbon-based structures for inhibiting growth of fibroblasts |
US8764696B2 (en) * | 2009-06-16 | 2014-07-01 | Mobius Therapeutics, Inc. | Medical drainage devices with carbon-based structures for inhibiting growth of fibroblasts |
US20140248454A1 (en) * | 2009-06-16 | 2014-09-04 | Mobius Therapeutics, Llc | Medical drainage devices with carbon-based structures for inhibiting growth of fibroblasts |
US10149963B2 (en) | 2010-05-11 | 2018-12-11 | Vital 5, Llc | Catheter assembly |
US9446224B2 (en) | 2010-09-22 | 2016-09-20 | Vital 5, L.L.C. | Barrier catheter |
US9265913B2 (en) | 2010-09-22 | 2016-02-23 | Vital 5, Llc | Catheter assembly |
USD679804S1 (en) | 2011-09-22 | 2013-04-09 | Vital 5, Llc | Catheter |
US20130085468A1 (en) * | 2011-10-03 | 2013-04-04 | Yuri Buydenok | Catheter with body wall separator |
GB2496369A (en) * | 2011-10-17 | 2013-05-15 | Miles Charles Deholm Dalby | Catheter for delivering radiopaque material |
WO2013111057A1 (en) * | 2012-01-24 | 2013-08-01 | Kimberly-Clark Worldwide, Inc. | Drainage catheter system with cuff |
US11291473B2 (en) | 2012-03-15 | 2022-04-05 | Alydia Health, Inc. | Uterine hemorrhage controlling system and method |
US10064651B2 (en) | 2012-03-15 | 2018-09-04 | Inpress Technologies, Inc. | Uterine hemorrhage controlling system and method |
WO2014154186A1 (en) * | 2013-03-29 | 2014-10-02 | 广东百合医疗科技股份有限公司 | Minimally invasive thoracic cavity drainage surgical instrument conforming to human anatomical characteristics |
WO2014153691A1 (en) * | 2013-03-29 | 2014-10-02 | 广东百合医疗科技有限公司 | Human body anatomical feature compliant minimally invasive chest drainage tube and drainage surgery instruments |
WO2014153789A1 (en) * | 2013-03-29 | 2014-10-02 | 广东百合医疗科技股份有限公司 | Minimally invasive thoracic cavity drainage tube and drainage surgical instrument satisfying anthropotomical characteristics |
US11278708B2 (en) | 2014-01-15 | 2022-03-22 | Tufts Medical Center, Inc. | Endovascular cerebrospinal fluid shunt |
US10596357B2 (en) | 2014-01-15 | 2020-03-24 | Tufts Medical Center, Inc. | Endovascular cerebrospinal fluid shunt |
US9737696B2 (en) * | 2014-01-15 | 2017-08-22 | Tufts Medical Center, Inc. | Endovascular cerebrospinal fluid shunt |
US20150196741A1 (en) * | 2014-01-15 | 2015-07-16 | Tufts Medical Center, Inc. | Endovascular cerebrospinal fluid shunt |
US10058686B2 (en) | 2014-10-31 | 2018-08-28 | Cerevasc, Llc | Methods and systems for treating hydrocephalus |
US9724501B2 (en) | 2014-10-31 | 2017-08-08 | Cerevasc, Llc | Methods and systems for treating hydrocephalus |
US9669195B2 (en) | 2014-10-31 | 2017-06-06 | Cerevasc, Llc | Methods and systems for treating hydrocephalus |
US9662479B2 (en) | 2014-10-31 | 2017-05-30 | Cerevasc, Llc | Methods and systems for treating hydrocephalus |
US9545505B2 (en) | 2014-10-31 | 2017-01-17 | Cerevasc, Llc | Methods and systems for treating hydrocephalus |
US10765846B2 (en) | 2014-10-31 | 2020-09-08 | CereVasc, Inc. | Methods and systems for draining cerebrospinal fluid into the venous system |
US10279154B2 (en) | 2014-10-31 | 2019-05-07 | Cerevasc, Llc | Methods and systems for treating hydrocephalus |
US10307576B2 (en) | 2014-10-31 | 2019-06-04 | Cerevasc, Llc | Systems and methods for deploying an implant in the vasculature |
US11471583B2 (en) | 2015-07-20 | 2022-10-18 | Roivios Limited | Method of removing excess fluid from a patient with hemodilution |
US11612714B2 (en) | 2015-07-20 | 2023-03-28 | Roivios Limited | Systems and methods for inducing negative pressure in a portion of a urinary tract of a patient |
US11918754B2 (en) | 2015-07-20 | 2024-03-05 | Roivios Limited | Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion |
US11904121B2 (en) | 2015-07-20 | 2024-02-20 | Roivios Limited | Negative pressure therapy system |
US11896785B2 (en) | 2015-07-20 | 2024-02-13 | Roivios Limited | Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion |
US11752300B2 (en) | 2015-07-20 | 2023-09-12 | Roivios Limited | Catheter device and method for inducing negative pressure in a patient's bladder |
US11541205B2 (en) | 2015-07-20 | 2023-01-03 | Roivios Limited | Coated urinary catheter or ureteral stent and method |
US11420014B2 (en) | 2015-07-20 | 2022-08-23 | Roivios Limited | Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion |
JP7115930B2 (en) | 2015-07-20 | 2022-08-09 | ロイヴィオス リミテッド | Ureteral and bladder catheters and methods for inducing negative pressure to increase renal perfusion |
JP2018196754A (en) * | 2015-07-20 | 2018-12-13 | ストラタカ システムズ リミテッド | Urinary duct, bladder catheter, and method for inducing negative pressure for increasing kidney perfusion |
US10272230B2 (en) | 2015-10-30 | 2019-04-30 | Cerevasc, Llc | Systems and methods for treating hydrocephalus |
US11951270B2 (en) | 2015-10-30 | 2024-04-09 | Cerevasc, Llc | Systems and methods for endovascularly accessing a subarachnoid space |
US10307577B2 (en) | 2015-10-30 | 2019-06-04 | Cerevasc, Llc | Systems and methods for deploying an implant in the vasculature |
US10758718B2 (en) | 2015-10-30 | 2020-09-01 | CereVasc, Inc. | Systems and methods for endovascularly accessing a subarachnoid space |
WO2018039250A1 (en) * | 2016-08-24 | 2018-03-01 | Inpress Technologies, Inc. | Uterine hemorrhage controlling system and method |
US11517336B2 (en) | 2016-08-24 | 2022-12-06 | Alydia Health, Inc. | Uterine hemorrhage controlling system and method |
US10307566B2 (en) * | 2017-07-05 | 2019-06-04 | Duke University | Drainage or infusion catheter and method of use |
US11291797B2 (en) | 2017-07-05 | 2022-04-05 | Duke University | Drainage or infusion catheter and method of use |
US20190009054A1 (en) * | 2017-07-05 | 2019-01-10 | Duke University | Drainage or infusion catheter and method of use |
US20210030590A1 (en) * | 2018-02-22 | 2021-02-04 | Ivantis, Inc. | Ocular implant and delivery system |
US11850390B2 (en) | 2018-03-08 | 2023-12-26 | CereVasc, Inc. | Systems and methods for minimally invasive drug delivery to a subarachnoid space |
US11013900B2 (en) | 2018-03-08 | 2021-05-25 | CereVasc, Inc. | Systems and methods for minimally invasive drug delivery to a subarachnoid space |
RU194110U1 (en) * | 2019-04-30 | 2019-11-28 | Федеральное Государственное Бюджетное Образовательное Учреждение Высшего Образования "Тюменский Государственный Медицинский Университет" Министерства Здравоохранения Российской Федерации | Hepatic drainage |
Also Published As
Publication number | Publication date |
---|---|
US20030191452A1 (en) | 2003-10-09 |
US7048729B2 (en) | 2006-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7048729B2 (en) | Catheter and method of fluid removal from a body cavity | |
EP1019142B1 (en) | Guidwire compatible access port assembly | |
US4368737A (en) | Implantable catheter | |
US8088112B2 (en) | Implantable medical site | |
US7465286B2 (en) | Loop-tip catheter | |
US9463268B2 (en) | Cannula systems and methods | |
US6238369B1 (en) | Method and systems for establishing vascular access | |
JP4335523B2 (en) | Peritoneal dialysis catheter | |
US20030171708A1 (en) | Ureteral stent | |
EP0509715A1 (en) | Peritoneal dialysis catheter | |
US11547545B2 (en) | Infusion filter and method for performing thrombolysis | |
US20220176087A1 (en) | System And Method For Treatment Via Bodily Drainage Or Injection | |
AU6142898A (en) | Suprapubic drainage catheter | |
BRPI0401080B1 (en) | DERIVATION SYSTEM FOR DRAINING FLUID IN A PATIENT AND UNDERSTANDING THE SYSTEM | |
EP0814865A1 (en) | Vascular access system | |
CA2278125A1 (en) | Methods and systems for establishing vascular access | |
CA2361039A1 (en) | Access system and methods having reversible cannulas | |
JP2003512893A (en) | Valve ports and methods for vascular access | |
US20230233310A1 (en) | Infusion filter and method for performing thrombolysis | |
US20230015625A1 (en) | Peritoneal dialysis catheter with an expandable structure | |
JPS6371257A (en) | Catheter for abdominal membrane infusion dialysis | |
CA1171334A (en) | Implantable catheter | |
JPS6371258A (en) | Catheter for abdominal membrane infusion dialysis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |